Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist

Objective To assess the effect of aromatase inhibitors with GnRH agonist for a severe symptomatic adenomyosis that is refractory to GnRH agonist and danazol with GnRH agonist. Design Case report. Setting Clinical practice in university hospital. Patient(s) A 34-year-old woman with a complaint of sev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fertility and sterility 2007-06, Vol.87 (6), p.1468.e9-1468.e12
Hauptverfasser:	Kimura, Fuminori, M.D., Ph.D, Takahashi, Kentaro, M.D., Ph.D, Takebayashi, Koichi, M.D., Ph.D, Fujiwara, Mutsuko, M.D, Kita, Nobuyuki, M.D., Ph.D, Noda, Yoichi, M.D., Ph.D, Harada, Nobuhiro, Ph.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenomyosis Adult aromatase inhibitor Aromatase Inhibitors - therapeutic use Buserelin - therapeutic use Endometriosis - drug therapy Endometriosis - pathology Female GnRH agonist Gonadotropin-Releasing Hormone - agonists Humans Internal Medicine Magnetic Resonance Imaging Obstetrics and Gynecology Premenopause Uterine Diseases - drug therapy Uterine Diseases - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!